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Abstract 
Background 
In 2008, Africa accounted for 94% of the cholera cases reported worldwide. Although the 
World Health Organization currently recommends the oral cholera vaccine in endemic areas 
for high-risk populations, its use in Sub-Saharan Africa has been limited. Here, we provide 
the principal results of an evaluation of the cholera surveillance system in the region of 
Maradi in Niger and an analysis of its data towards identifying high-risk areas for cholera. 
Results 
We evaluated the cholera surveillance data using a standard CDC protocol, through 
interviews with heads of the system, and a review of cholera data collected between 2006–
2009. The surveillance system was found to be sufficiently reliable to be able to utilize the 
data for the detection of high risk areas for cholera vaccination. Temporal, geographic and socio-demographic analyses of cholera cases indicated that between 2006 and 2009, 433 
cholera cases were reported in the Maradi region of Niger. Two deprived neighborhoods of 
the region’s capital city, Bagalam and Yandaka, represented 1 % of the regional population 
and 21 % of the cholera cases, reaching a yearly incidence rate of 3 per 1000 in 2006 and 
2008, respectively. 
Conclusions 
The results of this evaluation suggest that the reporting sensitivity of the surveillance system 
is sufficient, to appropriately classify the region as cholera endemic. Additionally, two 
overcrowded neighborhoods in the regional capital met WHO criteria for consideration for 
cholera vaccination. 
Background 
In 2008, Africa accounted for 94 % of the cholera cases reported to the World Health 
Organization (WHO). Niger reported a small fraction of these cases, although certain areas of 
the country face repeated epidemics [1,2]. From 2000 to 2008, Niger reported cholera 
outbreaks every year, mainly in the south of the country and totaling close to 6000 cases [2]. 
The region of Maradi has the highest population density in the country and regularly reports 
cholera cases [2]. 
Two safe and effective oral cholera vaccines (Dukoral and Shanchol) are now available and 
prequalified by WHO [3–5], with some evidence of induced herd immunity [6,7]. To 
optimize implementation in cholera-endemic areas, WHO guidance recommends targeting 
oral cholera vaccination to areas where culture-confirmed cholera has been detected in at 
least 3 of the past 5 years; and incidence rates are at least 1/1000 population in any of these 
years or high-risk areas or groups have been identified using information collected from local 
public health officials [8]. Thus, epidemiological knowledge of the burden of cholera in a 
specific area is required before cholera vaccination is recommended. Although WHO 
recommends the use of these vaccines in endemic areas, their use in Sub-Saharan Africa has 
been limited [9]. 
National cholera surveillance systems are an affordable way to collect epidemiological data 
before a cholera vaccination campaign is implemented. They must, however, be evaluated 
[10], and if sound, surveillance data can then be analyzed to identify high-risk areas suitable 
for cholera vaccination 
Here, we provide the results of an evaluation of the surveillance system in the region of 
Maradi, Niger and an analysis of its data towards identifying high-risk areas that may be 
considered for potential cholera vaccination. 
Methods 
The region of Maradi is divided into 6 administrative districts (Figure 1). Maradi city is the 
regional capital and the second largest city in Niger. In collaboration with the regional health 
authorities, we first evaluated the surveillance system in the region following a standard 
protocol developed by the Centers for Disease Control and Prevention (Atlanta, Georgia, USA) [10]. Subsequently we analyzed this surveillance data, using WHO criteria to identify 
high-risk areas to target oral cholera vaccination in cholera endemic areas [8]. 
Figure 1 Map of the region of Maradi 
Briefly, the surveillance system evaluation covered the simplicity, flexibility, reactivity, 
stability, representativeness and acceptability of the system as well as the quality of data, the 
positive predictive value (PPV) and sensitivity. The evaluation, conducted in 2009 examines 
historical data since 2006 extracted from the Ministry of Health (MoH) records. It included 
reviewing all reports issued by the cholera surveillance system for the same period, including 
case reports about the onset of epidemics and response to epidemics. The evaluation 
consisted principally of detailed structured interviews with the heads of the cholera 
surveillance system of the Maradi region and with the heads of the 6 health facilities of the 
city of Maradi. 
Using MoH surveillance records extracted for 2006–2009 and official population figures 
from the 2001 census, we estimated the cumulative incidence rates of cholera by year, 
administrative district and by neighborhood in Maradi city. For temporal analyses, we 
considered consultation date of the cholera cases and for geographic analyses the place of 
residence of cases. Available socio-demographic data (age and sex) were used to describe the 
cholera case population. For the identification of cholera endemic areas we apply the WHO 
definition of “the occurrence of fecal culture-confirmed cholera diarrhea in a population in at 
least 3 of the past 5 years” [8]. For the identification of high risk areas for potential cholera 
vaccination we apply WHO criteria of areas where 2 of the 3 following criteria are met: “(i) 
culture-confirmed cholera has been detected in at least 3 of the past 5 years; (ii) an incidence 
rate of cholera of at least 1/1000 population in any of these years has been recorded; (iii) if 
population-based incidence rates are not available, high-risk areas or groups have been 
identified using information collected from local public health officials” [8]. R statistical 
software [11] was used to analyze and present data collected from the surveillance system. 
Participating heads of surveillance system orally consented to be interviewed. Authorization 
was provided by the Ministry of Health of Niger. No additional ethical committee approval 
was sought as we used routine surveillance data provided by the MoH. No supplementary 
interventions were conducted nor additional data collected for the evaluation and analysis 
presented here. All data were anonymous and neither ethnic nor identifying information was 
included. 
Results 
The following paragraphs present first, an overview of the evaluation of the surveillance 
system, and second, an epidemiologic description of the surveillance system data to identify 
high risk-areas. 
The surveillance system in Niger is based on WHO reference guidelines [12], covering 7 
potential epidemic diseases, including cholera. No other surveillance system for cholera 
exists nationally. The surveillance system used the WHO standard case definition of cholera 
[12]: –  During an inter-epidemic period: any individual aged 5 years old or more who presented 
acute dehydration or who died of acute watery diarrhea. 
–  During an epidemic period: any individual aged 5 years old or more who presented an 
acute watery diarrhea with or without vomiting. 
Both public and private health facilities are required to report cholera cases and related deaths 
for persons over 5 years of age. Health facilities report disease data to their sanitary districts 
(with one epidemiologist in charge). Each district reports its data to the sanitary region, which 
in turn reports to the Ministry of Health. During a cholera epidemic, especially at its onset, 
the heads of the surveillance system at the district and regional level conduct field 
investigations in the affected areas in order to identify related cases. A case of cholera is 
confirmed when either Vibrio cholerae O1 or O139 is isolated from the stool sample of a 
suspected case. A cholera epidemic is declared as soon as the first case of cholera is 
confirmed. Key attributes of the cholera surveillance system for the evaluation of data are 
presented in Tables 1 and 2. Complete results of the surveillance system evaluation are 
available elsewhere [13]. The evaluation of the cholera surveillance system of the Maradi 
region showed a good sensitivity of the system to detect the cholera cases and good quality of 
reported information for persons 5 years of age and older. 
Table 1 Results of the interviews and data collection related with the data quality and 
sensitivity attributes of the surveillance system 
Attributes  Results of the interviews and data collection 
Data quality   
Completeness and 
validity of the data 
recorded   
Very few missing values were found: 0/403 for the administrative 
district, 3/403 for age, 1/403 for sex. Only data from 2006 to 2009 
were available at the regional level. 
Sensitivity   
Sensitivity to detect 
cholera cases during 
an inter-epidemic 
period   
Cholera cases were identified by the nurses in the healthcare 
facilities. Difficulties were reported in the detection of the first cases 
of cholera. Usually, the observation of a few cholera cases was 
necessary before reporting of suspected cases of cholera started. 
Sensitivity to detect 
cholera cases during 
an epidemic period   
During an epidemic, all the suspected cholera cases were referred to 
the cholera treatment centres (created at the onset of the epidemic), 
where they were documented. Surveillance system leaders conducted 
investigations to detect related cases and to inform the population 
about cholera. Radio messages were broadcasted to inform the 
population about cholera symptoms and encourage the reporting of 
any suspected case to the heads of healthcare facilities. Four heads of 
health structures reported that during epidemics, there was general 
awareness of the gravity of cholera and the population was more 
likely to seek care at healthcare facilities in case of acute diarrhea. 
Sensitivity to detect a 
cholera epidemic   
Each cluster of cholera cases was reported to the heads of the 
surveillance system. All interviewees felt confident that each cluster 
of cholera of cases was reported to the head of the surveillance 
system. Table 2 Results of the interviews and data collection related with the positive predictive 
value and representativeness attributes of the surveillance system 
Attributes  Results of the interviews and data collection 
Positive predictive value 
Positive predictive value 
during an inter-epidemic 
period   
For the initial fifth through tenth suspected cholera cases, stool 
samples were collected to perform stool cultures. This was done 
in the national laboratory in Niamey. Stool collection usually 
lacked for the first cholera cases. Tubes with Cary-Blair medium 
for the transport of the samples were not available from 2006 to 
2009. For 26 cholera cultures results from 2006 to 2009 
available at the time of the study, 13 were positive for Vibrio 
cholerea O1 ogawa (2 were positive for shigella and no 
pathogens were found for 11 cultures). 
Positive predictive value 
during an epidemic period 
Each epidemic was confirmed by stool culture. If an epidemic 
was confirmed with five to ten stool samples, stool collection 
and testing ceased. Four heads of health structures reported that 
during an epidemic, the population was aware of the gravity of 
cholera and that they were more likely to seek care at healthcare 
facilities in case of acute diarrhea. 
Representativeness   
Accurate description of 
cholera cases over time   
Each week, each healthcare facility completed the notifiable 
diseases reports, which include the number of cholera cases. 
When a cholera case is suspected, the head of the healthcare 
facility promptly contacted the district epidemiologist, who in 
turn contacted the regional responsible of the surveillance 
system. During an epidemic, the count of cholera cases was 
reported daily to the regional and national heads of the 
surveillance system. 
Accurate description of 
cholera cases by 
geographic location   
In remote villages, the first cholera cases did not seek care at 
healthcare facilities. After a few cases had been noted, the 
population tended to seek care at health facilities. 
Accurate description of 
cholera cases by socio-
demographics 
characteristics   
For each cholera case, specific forms were completed with 
accurate information including: age, sex, address, consultation 
date, report date, date of symptom onset, vital status, and final 
diagnosis.Individuals aged less than 5 years are not typically 
reported. Some cases in children under 5 were reported, 
however. 
Surveillance system data from 2006–2009 showed the following epidemiologic indicators. 
Four hundred and three cholera cases were reported in the region between 2006 and 2009, 
among which 18 (4.47 %) deaths were reported. No cases were reported in 2009. All 
epidemics occurred during the rainy season (Figure 2). Compared to the overall incidence 
rate of 0.05 per 1000 in the region for 2006 through 2009, the Maradi city incidence rate was 
0.27 per 1000 for the same period (Table 3 - Figure 3). From 2006 to 2009, the mean age of 
cholera cases was 25 years (Figure 4). During this period, 232 women and 170 men were 
reported as cholera cases (sex ratio = 0.73, sex not available for 1 case). In the city, the 
deprived neighborhoods of Bagalam and Yandaka, which represent 1 % of the regional 
population, reported 21 % of the cholera cases (n = 85). Incidence rates of 3 per 1000 were 
recorded in those neighborhoods in 2006 or 2008 (Table 4 - Figure 5). Figure 2 Temporal distribution of cholera cases in the region of Maradi 
Table 3 Cholera cases reported to the national surveillance system between 2006 and 
2009 by administrative district 
Administrative 
districts of the 
region of 
Maradi
* 
2006  2007  2008  Total 2006-2009
† 
Cholera 
cases 
Incidence
‡ Cholera 
cases 
Incidence
‡ Cholera 
cases 
Incidence
‡ Cholera 
cases 
Incidence
‡ 
Aguié      0  0.00  18  0.07      0  0.00    18  0.02 
Dakoro      0  0.00    0  0.00      0  0.00      0  0.00 
Guidan 
Roumdji 
    6  0.02    0  0.00      4  0.01    10  0.01 
Madarounfa  130  0.46    0  0.00      1  0.00  131  0.11 
City of Maradi    73  0.50    0  0.00    86  0.58  159  0.27 
Mayahi      0  0.00    0  0.00    30  0.08    30  0.02 
Tessaoua      0  0.00    0  0.00    55  0.16    55  0.04 
Total region  209  0.09  18  0.01  176  0.08  403  0.05 
*The city of Maradi is listed separately although it is included in the administrative district of 
Madarounfa 
†No cholera cases were reported in 2009 
‡Incidence rates per 1000 inhabitants 
Figure 3 Distribution of cholera cases in the region of Maradi over 3 years 
Figure 4 Distribution of cholera cases by neighborhood in the city of Maradi 
Table 4 Cholera cases in the city of Maradi reported to the national surveillance system 
between 2006 and 2009 by neighbourhood 
  2006  2008  Total 2006-2009
* 
Neighborhoods of the city 
of Maradi 
Cholera 
cases 
Incidence
† Cholera 
cases 
Incidence
† Cholera 
cases 
Incidence
† 
Ali Dan Sofo    0  0.00    2  0.25    2  0.06 
Bagalam  40  3.08  19  1.46  59  1.14 
Bourja    1  0.09    0  0.00    1  0.02 
Bouzou Dan Zamba    1  0.10    0  0.00    1  0.03 
Dan Goulbi    1  0.21    1  0.21    2  0.11 
Limantchi
‡    1      2      3   
Makoyo    2  0.29    3  0.43    5  0.18 
Maradoua    1  0.06    6  0.37    7  0.11 
Mazadou Djika    1  0.27    0  0.00    1  0.07 
Nouveau carré
‡    0      5      5   
Sabon Gari    5  0.24    4  0.19    9  0.11 
Soura Bildi    6  0.36    6  0.36  12  0.18 
Yandaka    2  0.25  24  2.99  26  0.81 
Zaria    5  0.19    0  0.00    5  0.05 Neighborhood not 
documented 
  7    14    21   
*No cholera cases were reported in 2007 and 2009 
†Incidence rates per 1000 inhabitants 
‡Population figures not available 
Figure 5 Age distribution of the cholera cases reported in the region of Maradi from 
2006 to 2009 and age distribution of the inhabitants of the region of Maradi in 2001 
The Maradi region met the WHO criteria for endemic cholera, while Bagalam and Yandaka 
neighborhoods were identified as consistent high-risk areas for cholera within the city of 
Maradi and met the criteria for cholera vaccination according to the WHO recommendations. 
Discussion 
We evaluated the cholera surveillance system of the region of Maradi and found the system 
sufficient to appropriately identify endemic and high risk areas for potential cholera 
vaccination. 
Overall, the evaluation of the surveillance system suggests that the system is reasonably 
sensitive and that collected data are representative of the distribution of cholera cases in the 
region. Initial cholera cases were missed, but most were subsequently identified and 
recorded. Furthermore, the systematic realization of stool cultures in suspected cholera 
clusters and the high transmissibility of the disease made it unlikely that an epidemic of 
cholera would evade the surveillance system. 
Few missing values were found. This may be due to the regional centralization of the 
surveillance system during cholera epidemics where data are checked daily at the regional 
level. This increased communication and feedback loop between local and regional levels 
helps to improve data quality. Interviews with surveillance system officers also asserted that 
seeking health care in case of diarrhea during a cholera epidemic was common. Thus, for 
people older than 5 years of age, and especially in areas with health care facilities, non-
reported severe cholera cases should have been rare. The data issued from Maradi’s 
surveillance system could be improved, but the quality sufficed to identify high-risk areas 
with confidence. 
Several limitations should be kept in mind when interpreting the results of the surveillance 
system assessment. First, the evaluation was retrospective and limited to a four year 
observation period during which only two had a large number of reported cases. Second, due 
to logistical constraints, information about cholera surveillance outside Maradi city was filled 
by regional heads only, while within the city all the heads of health facilities were also 
interviewed. In all cases, however, it was possible to contrast findings from interviews with 
surveillance system reports. Third, as there was no alternative surveillance system for 
comparison, the evaluation was based solely on a retrospective review of MoH records, 
reports and personal interviews. Consequently sensitivity was assessed qualitatively. Fourth, 
initial clinically suspected cases were laboratory confirmed, but as testing ceased after the 
epidemic was confirmed, a specific study would be necessary to fully evaluate the system’s 
PPV. Lastly, the surveillance system was designed to capture cases 5 years of age and older. While this follows WHO surveillance recommendations, it does necessarily result in an 
underestimation of cases in this age-group. 
As an estimated 40 % of the population resides more than 5 km from a health facility [14], 
under-reporting from these more distal areas could lead to inaccurate epidemiological 
estimations. In fact, sensitivity at the onset of epidemics appears to have been lower in rural 
areas, especially in remote villages and health centres. Due to cholera’s severity and high 
transmissibility, however, and supported by the results of our evaluation, it appears that most 
originally missed cases were retrospectively recorded by health authorities. Conversely, an 
overestimation of cholera cases may have occurred, particularly in urban areas due to over-
attribution of non-cholera diarrheas. The clustering of cholera cases in Maradi, in addition to 
most neighborhoods reporting no cases suggests that over-reporting did not play a major role 
either. 
An additional limitation applies to the calculation of incidence rates. Population data from the 
2001 census would likely underestimate the population figures during the period 2006–2009, 
resulting in an overestimation of incidence rates in the study period. Cholera caseload could, 
however, as noted in Bangladesh be several-fold higher than the figure presenting at hospitals 
[15]. Furthermore, the system does not routinely report cases under 5 years of age, which in 
some Asian and African settings present with higher attack rates and are more prone to be 
hospitalized during cholera epidemics [16,17]. Consequently it is more likely that cholera 
incidence rates are higher than presented here, despite the population underestimation. 
Our evaluation suggests that the cholera surveillance system in place during the reviewed 
period is reasonably sensitive and could be used for detection of areas at risk for cholera 
epidemics. WHO criteria to implement a vaccination campaign [8] were met in the 
neighborhoods of Bagalam and Yandaka in the city of Maradi. The city of Maradi is the 
major transport trade and agricultural hub of the region. These neighborhoods are also among 
the poorest of the city, over-crowded and are susceptible to flooding. These factors may 
explain why the city took a major part in the spread of cholera epidemics, particularly in the 
overcrowded, poor sanitation neighborhoods of Bagalam and Yandaka. Following this 
evaluation and identification, these two neighborhoods are being considered for a cholera 
vaccination campaign. Of the two currently available prequalified oral cholera vaccines, 
Shanchol does not require a buffer or water for administration, is less expensive and 
potentially promising for use in contexts with limited sanitation infrastructures[18]. In 
overcrowded, poor sanitation neighborhoods in the city of Beira, Mozambique, Jeuland et al 
estimated that a vaccination campaign targeting the whole 1–14 year-old population would be 
very cost-effective [19], despite the logistical difficulties to its implementation. The 
implementation of a similar long-term oral cholera vaccination campaign in the identified 
neighborhoods of Bagalam and Yandaka may present similar results, until associated water 
and sanitation infrastructure are improved. 
Conclusion 
By evaluating the surveillance system and subsequently the surveillance data, the Maradi 
region could be considered endemic for cholera. Two high risk neighborhoods in the regional 
capital were identified as candidates for preventive cholera vaccination. This case study 
shows that evaluation of surveillance systems and the use of its data, when reliable, can be an efficient approach for the identification of high-risk areas for cholera in low- and middle-
income settings before considering cholera vaccination campaigns. 
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